Association between XRCC2 Arg188His Polymorphism and Breast Cancer Susceptibility: A Systematic Review and
Seyed Alireza Dastgheib1, Soheila Sayad2, Sepideh Azizi3
1Department of Medical Genetics, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Asian Pacific Journal of Cancer Prevention : APJCP
|January 29, 2024
Summary
The Arg188His polymorphism in X-ray repair cross-complementing 2 (XRCC2) gene shows a marginal association with global breast cancer susceptibility. This genetic variation may increase breast cancer risk, particularly in Caucasian populations.
Area of Science:
- Oncology
- Genetics
- Molecular Epidemiology
Background:
- Breast cancer is a leading cause of cancer-related death in women globally.
- The association between the X-ray repair cross-complementing 2 (XRCC2) Arg188His polymorphism (rs3218536) and breast cancer risk is currently ambiguous.
- Clarifying this association is crucial for understanding genetic predispositions to breast cancer.
Approach:
- A comprehensive meta-analysis was conducted, systematically searching PubMed, Google Scholar, and ISI Web of Science.
- Seventeen studies comprising 5694 breast cancer cases and 6450 healthy controls were included.
- Odds ratios (OR) and 95% confidence intervals (CI) were used to evaluate the strength of the association.
Key Points:
- The pooled analysis indicated a marginal association between the XRCC2 Arg188His polymorphism and breast cancer susceptibility globally (OR=0.929, 95% CI=0.873-0.987).
- Subgroup analysis by ethnicity revealed a significant association among Caucasian populations.
- The heterozygote contrast model showed a statistically significant result (p=0.018).
Conclusions:
- The XRCC2 Arg188His polymorphism may contribute to an increased risk of developing breast cancer.
- Further research is warranted to fully elucidate the role of XRCC2 polymorphisms in breast cancer etiology.
- Genetic variations in DNA repair genes like XRCC2 are important factors in cancer risk assessment.
Related Concept Videos
Genome-wide Association Studies-GWAS
13.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.4K
Single Nucleotide Polymorphisms-SNPs
15.1K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.1K


